Windward Bio has landed with a flurry of announcements, circling in a $200 million series A and offering up to $970 million ...

Novel antibodies have the potential to pave the way for the next generation of malaria interventions. Researchers at the ...

A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new ...

Funding will propel Leyden Labs’ non-vaccine intranasal antibody programs to safeguard people from respiratory viruses. The ...

The therapy showed a ‘favourable’ safety profile both as a single agent and in combination with standard-of-care treatment.

The report analyzes the growth rate, market size, and market valuation for the forecast period. This report covers aspects of the regional analysis market. The report includes data about North America ...

Eliem Therapeutics is continuing its transformation into an immune-mediated disease company by paying $9 million to ...

Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody therapeutics, announced the licensing of its fully human antibodies to ...